Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-PSMA-1007 PET/CT in Prostate Cancer
NCT05520255Phase 3Recruiting
- Sponsor
- University of Alberta
- Start
- Jul 2023
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of radelumin in prostate cancer (PCa), sponsored by University of Alberta. Started Jul 2023; status: recruiting.
02
Drugs
radelumin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05520255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05520255.